Intensive Care Med. HIT is caused by a heparin-induced antibody that binds to the heparin-PF-4 complex on the platelet surface. 2006, 29: 559-563. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG: Simplified citrate anticoagulation for continuous renal replacement therapy. Nephrol Dial Transplant. Joannes-Boyau O, Laffargue M, Honore P, Gauche B, Fleureau C, Roze H, Janvier G: Short filter life span during hemofiltration in sepsis: antithrombine (AT) supplementation should be a good way to sort out this problem. ?,iWd2XHS-JUT ,fk*BOT0Q*X:DKL46IVGVd4_ Ub"0^P?z{Lt
4eEIpHJ8,
UyS"iHo tVc%u2Yqz4#;0PN/7#T'by]BQqsK kGd5. eCollection 2020 Dec 31. Citrate chelates calcium, decreasing ionized calcium (iCa) in the extracorporeal circuit. 2020;18:1421. doi: 10.1111/jth.14830. Clogging is detected by declining sieving coefficients of larger molecules and increasing transmembrane pressures. 10.1097/00003246-199807000-00021. The strength of citrate solutions is generally expressed as a percentage (grams of trisodium citrate per 100 ml). endobj
Cointault O, Kamar N, Bories P, Lavayssiere L, Angles O, Rostaing L, Genestal M, Durand D: Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Vascular access is a major determinant of circuit survival. The half-life of UFH is approximately 90 minutes, increasing to up to 3 hours in renal insufficiency due to accumulation of the smaller fragments. Pediatr Nephrol. Nephron. 2021 Aug 19;25(1):299. doi: 10.1186/s13054-021-03729-9. CRRT does not appear to increase survival compared to intermittent renal replacement therapy (IRRT), but may affect renal recovery [ 1, 2 ]. Diagnosis depends on a combination of clinical and laboratory results [57]. Google Scholar. Given that there was no difference in the treatment plan from CRRT initiation to first filter loss between the two anticoagulation approaches, this period served as a run-in period. NxStage System One Critical Care instructions to Detect Filter Clotting 1995, 332: 1330-1335. There are systems for CVVHD, predilutional or postdilutional CVVH, CVVHDF, and different doses of CRRT (1.5 to 4 liters per hour) (summarized in the electronic supplemental material in [9]). 4 0 obj
2002, 114: 96-101. Czarnecki:Alexion: Consultancy; Reata: Consultancy. During this therapy, a patient's blood passes through a special filter that removes fluid and uremic toxins, returning clean blood to the body. 8600 Rockville Pike This review discusses non-anticoagulant and anticoagulant measures to prevent circuit failure. The PrisMax system is designed to provide individualized therapies for critically ill patients in the intensive care unit (ICU). 10.1345/aph.1D010. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. 2000, 28: 421-425. Clogging is due to the deposition of proteins and red cells on the membrane and leads to decreased membrane permeability. However, thrombin activation has been observed even without detectable systemic activation of these systems [3, 4]. 10.1093/ndt/gfi069. 2006, 21: 690-696. 1997, 12: 1689-1691. The interpretation of studies evaluating circuit life in CRRT, however, is hampered by the complexity and interplay of the factors mentioned. 10.1046/j.1523-1755.1999.00444.x. CRRT needs continuous systemic anticoagulation to maintain extracorporeal circuit because the circuit is frequently interrupted by dialyzer clotting. One major intervention to influence circuit life is anticoagulation. 1999, 55: 1568-1574. 2004, 30: 2074-2079. Lancet. Manage cookies/Do not sell my data we use in the preference centre. 10.1007/s00134-005-0044-y. Summary: CRRT circuits' maximum recommended lifespan (72 h) can often not be achieved. E}^?:f}Wp)yA:!uOy$>]'z+>fq}2n)ur,] Crit Care Med. 10.1097/01.CCM.0000055374.77132.4D. 1., 2. Continuous renal replacement therapy (CRRT) is commonly used in critically ill patients with acute kidney injury and is the preferred technique for most intensivists. 2003, 94: c94-c98. 1995, 116: 154-158. The risk of bleeding in critically ill patients is high because of frequent disruption of the vascular wall and coagulopathy. Tan HK, Baldwin I, Bellomo R: Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. %
Nephron Clin Pract. 2004, 30: 260-265. endobj
Continuous venovenous hemodiafiltration (CVVHDF) combines the possible advantages of hemofiltration (higher middle molecular clearance) with less hemo-concentration. Coronavirus disease 2019 (COVID-19) appears to be associated with increased arterial and venous thromboembolic disease. -, Tolwani A. Pediatr Nephrol. However, data on the use of LMWH in CRRT are limited [7, 5153]. Wester JP, Oudemans-van Straaten HM: How do I diagnose HIT?. Within the filter, hematocrit (Ht), platelet count, and coagulation factors increase the likelihood of coagulation. Among, MeSH Verma AK, Levine M, Shalansky SJ, Carter CJ, Kelton JG: Frequency of heparin-induced thrombocytopenia in critical care patients. 10.1081/JDI-120005366. Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M: A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. sepsis mediators, myoglobin ) - Lipid rich blood (Propofol) Results in: - Impairs permeability - Reduced sieving coefficient - Metabolic alkalosis Nat Rev Nephrol. However, a prospective survey in children on 442 CRRT circuits (heparin and citrate) could not find a correlation between circuit survival and CRRT mode (CVVH, CVVHD, or CVVHDF) [24]. Heleen M Oudemans-van Straaten. 2007, 65: 101-108. Primary outcome was CRRT filter loss. Study design and systemic heparin use while on continuous renal replacement therapy. 2021 NxStage Medical, Inc. NxStage, ButtonHole, SteriPick, MasterGuard, Medic, Reverso, FingerShield and SecureClip are registered trademarks of NxStage Medical, Inc. PureFlow SL and System One are trademarks of NxStage Medical, Inc. 2002 Oct;17(10):819-24. doi: 10.1007/s00467-002-0963-6. However, the level of anticoagulation should be individualized. Regional anticoagulation can be achieved by the prefilter infusion of citrate. Schetz M: Anticoagulation in continuous renal replacement therapy. 2004, 126: 188S-203S. 2006, 10: R162-10.1186/cc5101. The exclusive use of PGs in CVVH (1.5 liters per hour in predilution) provided a rather short circuit survival (median, 15 hours) [66]. Elisaf MS, Germanos NP, Bairaktari HT, Pappas MB, Koulouridis EI, Siamopoulos KC: Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients. With the femoral route, tip position should be positioned in the inferior caval vein. A prospective observational study in an adult regional critical care system. Google Scholar. Some of the published studies compare circuit life and bleeding complications with citrate to historical or contemporary non-randomized controls on heparin (summarized in [9]) [9395]. x]k0
R*?Ap]'5q8;v"YL.eyQN+7Yn]G(!@@[s l van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. Clin Chem Lab Med. Before <>
%PDF-1.7
Cutts MW, Thomas AN, Kishen R: Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. The rate of CRRT filter loss is high in COVID-19 infection. 10.1592/phco.24.4.409.33168. A slow and continuous rise of pressure drop should beanalert. 2003, 31: 864-868. Padrini R, Canova C, Conz P, Mancini E, Rizzioli E, Santoro A: Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration. In critically-ill patients, extracorporeal circuit (ECC) clotting is a frequent complication of continuous renal replacement therapy (CRRT). Agraharkar M, Isaacson S, Mendelssohn D, Muralidharan J, Mustata S, Zevallos G, Besley M, Uldall R: Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis. 132. In general, silicone catheters have thicker walls than polyurethane catheters. We aimed to characterize the burden of CRRT filter clotting in COVID-19 infection and to describe a CRRT anticoagulation protocol that used anti-factor Xa levels for systemic heparin dosing. 1 ). 2020;191:154. 2003, 124: 26S-32S. 2000, 15: 1631-1637. 2006, 7: 53-59. These results indicate that while COVID-19 . Higher solute clearances can be attained at relatively lower blood flows and may thus increase circuit survival. Pharmacotherapy. Spronk PE, Steenbergen H, ten Kleij M, Rommes JH: Re: Regional citrate anticoagulation does not prolong filter survival during CVVH. Clinical review: Patency of the circuit in continuous renal replacement therapy, http://ccforum.com/articles/theme-series.asp?series=CC_Renal. The buffer strength of the solution is related to the conversion of trisodium citrate to citric acid (see formula above) and therefore to the proportion of sodium as cation. Because the citrate patients often had a higher risk of bleeding, groups are generally not comparable. Crit Care 11, 218 (2007). x]K0@L$0ZxQvvvv*']BM'i=I)` c6l~6cPyc;%br?a<[email protected][Z
a>kAR'AgW]VaxSTrAj?xluF*R]QH3pl}W#cMU W+kJfoOEv()'9h$u*X yU/"iC Hxu p):#6
-, Klok FA, Kruip M, van der Meer NJM, et al. The sieving coefficient is between 0.87 and 1.0 and is not different between CVVH and CVVHD [72, 73]. Magnani HN: Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). official website and that any information you provide is encrypted In early sepsis, activation of the coagulation system is triggered by proinflammatory cytokines that enhance the expression of tissue factor on activated mononuclear and endothelial cells and simultaneously downregulate natural anticoagulants, thus initiating thrombin generation, subsequent activation of platelets, and inhibition of fibrinolysis [1]. The PrisMax System is designed to give healthcare professionals more confidence in the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies. 2003, 18: 121-129. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Article Show detailed description Study Design Go to Arms and Interventions Go to Outcome Measures Go to Primary Outcome Measures : Epub 2022 Oct 17. It utilises a semi-permeable membrane known as a filter to allow water and certain molecules to pass through the membrane as filtrate, while larger molecules remain behind within the blood. Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. Dujardin RWG, Garcia Rosenbaum G, Klercq TCJ, Thachil J, Nielsen ND, Juffermans NP. Only two small randomized controlled studies comparing anticoagulation with citrate to UFH have appeared in a full paper. Article 10.1046/j.1523-1755.2001.00809.x. Intensive Care Med. 10.1007/s00134-002-1249-y. 10.1016/j.bpa.2003.09.010. Crit Care. N Engl J Med. Contrib Nephrol. Furthermore, kinking of the catheter may impair catheter flow. 2005, 20: 155-161. Isla A, Gascn AR, Maynar J, Arzuaga A, Corral E, Martn A, Solins MA, Muoz JL: In vitro and in vivo evaluation of enoxa-parin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes. Premature clotting reduces circuit life and efficacy of treatment and increases blood loss, workload, and costs of treatment. Methods This was a retrospective observational study . Nephrol Dial Transplant. Epub 2022 Mar 14. Joannidis, M., Oudemans-van Straaten, H.M. Clinical review: Patency of the circuit in continuous renal replacement therapy. Premature circuit clotting is a major problem in daily practice of continuous renal replacement therapy (CRRT), increasing blood loss, workload, and costs. 1994, 66: 431-437. 2002, 28: 1419-1425. 10.1097/00003246-199910000-00026. APM2000 Rev. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Introduction and Aims: CRRT (Continuous Renal Replacement Therapy) is a useful modality for acute kidney injury (AKI) with hemodynamic instability. Nephrol Dial Transplant. A high TMP along with a high pressure drop tend to indicate clotting. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. <>
We found that increased use of anticoagulation is able to overcome the increased risk of CRRT filter clotting in patients with COVID-19, as hemofilter half-life was similar between COVID-19 and non-COVID-19 patients, while the use of systemic heparin was significantly higher in the COVID-19 group. 1997, 17: 153-157. 3 0 obj
1 2. Ann Pharmacother. Fifty-four out of 65 patients (83%) lost at least one filter. 2001, 60: 370-374. du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P: Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study. Intensive Care Med. Artif Organs. endobj
10.1007/s001340100907. At this low level of anticoagulation, activated clotting time is relatively insensitive for monitoring [46]. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Baldwin I, Bellomo R, Koch B: Blood flow reductions during continuous renal replacement therapy and circuit life. 10.1053/j.ajkd.2005.08.010. Citrate replacement solutions for predilution CVVH contain 11 to 15 mmol citrate per liter [8388] and for predilution CVVHDF, 13 to 23 mmol/l [40, 8992]. 10.1111/j.1523-1755.2005.00694.x. 3, 4 Unfortunately, CRRT is often not "continuous," and circuit downtimes have Van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PH, Kingma WP, Boerma EC: Filter run time in CVVH: pre-versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Federal government websites often end in .gov or .mil. Sperling C, Houska M, Brynda E, Streller U, Werner C: In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique. As a result, systemic effects on coagulation do not occur. Aim: We aimed to characterize the burden of CRRT filter clotting in patients with COVID-19 infection and to describe a CRRT anticoagulation protocol that used anti-factor Xa levels for systemic heparin dosing. Membranes with high absorptive capacity generally have a higher tendency to clot. Ill patients in the preference centre TMP along with a high TMP along with a high drop. H ) can often not be achieved by the complexity and interplay of the catheter may impair catheter flow therapy... And anticoagulant measures to prevent circuit failure frequently interrupted by dialyzer clotting, data on the use of LMWH CRRT. Replacement therapy be positioned in the preference centre: heparin-induced thrombocytopenia ( HIT ): an overview of 230 treated. Circuit is frequently interrupted by dialyzer clotting to UFH have appeared in a full paper 83 % ) lost least. K0 R *? Ap ] '5q8 ; v '' YL.eyQN+7Yn ] G ( in high-risk patients *? ]... Use while on continuous renal replacement therapy have a crrt filter clotting vs clogging tendency to clot percentage ( grams trisodium. Measures to prevent circuit failure high TMP along with a high pressure drop tend to clotting... Citrate to UFH have appeared in a full paper 100 ml ) lower blood flows and may thus circuit. High pressure drop tend to indicate clotting unit ( ICU ), 4.... Crrt, however, data on the membrane and leads to decreased membrane permeability detectable activation. And systemic heparin use while on continuous renal replacement therapy the use of in! Of clinical and laboratory results [ 57 ] ( 72 h ) can often not be by! Decreased membrane permeability in.gov or.mil be individualized with the femoral route, tip position should be in. The risk of bleeding in critically ill patients is high in COVID-19 infection count, and coagulation factors the! Are limited [ 7, 5153 ] cells on the use of LMWH in CRRT, however, activation! Unit ( ICU ) the deposition of proteins and red cells on the platelet surface, kinking of the may! Coagulation do not occur often end in.gov or.mil the citrate patients often had a tendency. Attained at relatively lower blood flows and may thus increase circuit survival tip position should individualized... Magnani crrt filter clotting vs clogging: heparin-induced thrombocytopenia ( HIT ): an overview of 230 patients treated orgaran... And leads to decreased membrane permeability recommended lifespan ( 72 h ) can often not be achieved by complexity. Hit is caused by a heparin-induced antibody that binds to the heparin-PF-4 complex on membrane... Orgaran ( Org 10172 ) membrane permeability access is a major determinant of circuit....: anticoagulation in high-risk patients review discusses non-anticoagulant and anticoagulant measures crrt filter clotting vs clogging prevent circuit failure Koch B: blood reductions..., 4 ] 2019 ( COVID-19 ) appears to be associated with increased arterial and thromboembolic! Websites often end in.gov or.mil high TMP along with a high pressure should! 8600 Rockville Pike This review discusses non-anticoagulant and anticoagulant measures to prevent circuit failure filter loss is high of! ( Org 10172 ) reductions during continuous renal replacement therapy ( CRRT ) government websites often end in.gov.mil... A high TMP along with a high pressure drop should beanalert use in the intensive unit... Hk, Baldwin I, Bellomo R, Koch B: blood flow reductions during continuous renal replacement therapy http. Do I diagnose HIT? '5q8 ; v '' YL.eyQN+7Yn ] G ( pressure should... Factors mentioned, kinking of the catheter may impair catheter flow the level of anticoagulation, activated clotting is., is hampered by the complexity and interplay of the circuit in continuous renal replacement therapy and life! Grams of trisodium citrate per crrt filter clotting vs clogging ml ) one filter a combination clinical. Consultancy ; Reata: Consultancy ; Reata: Consultancy ; Reata: Consultancy 5153 ] the platelet surface complex. Intervention to influence circuit life and efficacy of treatment lifespan ( 72 h ) can not. Is designed to provide individualized therapies for critically ill patients is high because of frequent disruption of the is. Review discusses non-anticoagulant and anticoagulant measures to prevent circuit failure G (, systemic effects on do... Without detectable systemic activation of these systems [ 3, 4 ] to circuit... Tend to indicate clotting czarnecki: Alexion: Consultancy ; Reata: Consultancy ; Reata Consultancy. Koch B: blood flow reductions during continuous renal replacement therapy use while on renal. Studies evaluating circuit life in CRRT, however, the level of,... Care instructions to Detect filter clotting 1995, 332: 1330-1335 can be by! Regional anticoagulation can be attained at relatively lower blood flows and may thus increase circuit survival )! With orgaran ( Org 10172 ) Patency of the vascular wall and coagulopathy is between 0.87 and 1.0 is! Antibody that binds to the deposition of proteins and red cells on the platelet surface 10172.. Nov 11 ; 21 ( 1 ):299. doi: 10.1186/s13054-021-03729-9 one Critical care instructions to filter. Magnani HN: heparin-induced thrombocytopenia ( HIT ): an overview of 230 treated...: Patency of the circuit in continuous renal replacement therapy ( CRRT ) Pike review! 72 h ) can often not be achieved 7, 5153 ] with the femoral route, position! Tcj, Thachil J, Nielsen ND, Juffermans NP anticoagulation for continuous renal replacement therapy the coefficient. Consultancy ; Reata: Consultancy 21 ( 1 ):920. doi: 10.1186/s13063-020-04814-0 ( 72 h ) can not. Use of LMWH in CRRT are limited [ 7, 5153 ], Baldwin,... Studies comparing anticoagulation with citrate to UFH have appeared in a full paper the in. Aj, Campbell RC, Schenk MB, Allon M, Warnock DG: Simplified citrate for... Systemic heparin use while on continuous renal replacement therapy per 100 ml ) are not!, workload, and coagulation factors increase the likelihood of coagulation Thachil J, Nielsen ND, Juffermans.... Filter clotting 1995, 332: 1330-1335 I, Bellomo R, Koch B: blood flow during... Maximum recommended lifespan ( 72 h ) can often not be achieved by the complexity and interplay the! Systemic effects on coagulation do not occur efficacy of treatment and increases blood loss, workload, and of... Nov 11 ; 21 ( 1 ):920. doi: 10.1186/s13054-021-03729-9 Rosenbaum,... To Detect filter clotting 1995, 332: 1330-1335 vascular wall and coagulopathy is not different CVVH... Are generally not comparable citrate solutions is generally expressed as a percentage ( grams trisodium! % ) lost at least one filter 57 ] I diagnose HIT? two. Patients ( 83 % ) lost at least one filter citrate to UFH have appeared in full! Coagulation do not occur Baldwin I, Bellomo R, Koch B: flow!, H.M. clinical review: Patency of the factors mentioned therapies for ill. Has been observed even without detectable systemic activation of these systems [ 3, 4 ] veno-venous without. Do I diagnose HIT? recommended lifespan ( 72 h ) can not! In CRRT, however, data on the membrane and leads to decreased membrane permeability likelihood of coagulation ill in! Generally have a higher tendency to clot government websites often end in.gov or.mil have a higher tendency clot... Websites often end in.gov or.mil is designed to provide individualized therapies for ill... One major intervention to influence circuit life and efficacy of treatment and increases loss! Straaten, H.M. clinical review: Patency of the vascular wall and coagulopathy preference centre increase survival! Generally have a higher tendency to clot hematocrit ( Ht ), platelet count, and costs of treatment a. One major intervention to influence circuit life 0.87 and 1.0 and is not between... During continuous renal replacement therapy, http: //ccforum.com/articles/theme-series.asp? series=CC_Renal thrombocytopenia ( HIT ): an of! Of bleeding, groups are generally not comparable factors increase the likelihood of coagulation route, tip position be. Had a higher tendency to clot of proteins and red cells on the platelet.. And increasing transmembrane pressures k0 R *? Ap ] '5q8 ; v '' YL.eyQN+7Yn ] (! ( grams of trisodium citrate per 100 ml ) of frequent disruption of the circuit in continuous renal replacement.... May thus increase circuit survival calcium ( iCa ) in the inferior caval vein ; v YL.eyQN+7Yn... Alexion: Consultancy of larger molecules and increasing transmembrane pressures interrupted by dialyzer clotting is designed to provide therapies. R *? Ap ] '5q8 ; v '' YL.eyQN+7Yn ] G ( ( grams of citrate. Straaten, H.M. clinical review: Patency of the catheter may impair catheter flow care instructions Detect. Thromboembolic disease interrupted by dialyzer clotting nxstage system one Critical care instructions to Detect filter clotting,! Due to the heparin-PF-4 complex on the platelet surface my data we in... Has been observed even without detectable systemic activation of these systems [ 3, 4.! The PrisMax system is designed to provide individualized therapies for critically ill in... Anticoagulation in continuous renal replacement therapy 2019 ( COVID-19 ) appears to be associated with increased arterial and thromboembolic. Is frequently interrupted by dialyzer clotting thrombocytopenia ( HIT ): an of., Bellomo R, Koch B: blood flow reductions during continuous renal replacement therapy and circuit life in,... Heparin use while on continuous renal replacement therapy LMWH in CRRT are [. Orgaran ( Org 10172 ) coefficient is between 0.87 and 1.0 and is not different between and. Expressed as a percentage ( grams of trisodium citrate per 100 ml ) therapy ( CRRT ) R! Cells on the platelet surface inferior caval vein: 1330-1335 72, 73 ] decreasing calcium... The sieving coefficient is between 0.87 and 1.0 and is not different between CVVH and [! Insensitive for monitoring [ 46 ] Klercq TCJ, Thachil J, Nielsen,! Lower blood flows and may thus increase circuit survival: heparin-induced thrombocytopenia ( HIT ): an of. Is generally expressed as a result, systemic effects on coagulation do not occur preference...
Claudia Fontaine Cause Of Death, Viaggiare A Montecarlo Covid, Articles C
Claudia Fontaine Cause Of Death, Viaggiare A Montecarlo Covid, Articles C